APA (7th ed.) Citation

M, A., S, H., A, H., & A, K. (2022). Dinutuximab beta in the treatment of high-risk neuroblastoma: A follow-up of a case series in Bratislava. Medicine, 101(4), e28716. https://doi.org/10.1097/MD.0000000000028716

Chicago Style (17th ed.) Citation

M, Achbergerová, Hederová S, Hrašková A, and Kolenová A. "Dinutuximab Beta in the Treatment of High-risk Neuroblastoma: A Follow-up of a Case Series in Bratislava." Medicine 101, no. 4 (2022): e28716. https://doi.org/10.1097/MD.0000000000028716.

MLA (9th ed.) Citation

M, Achbergerová, et al. "Dinutuximab Beta in the Treatment of High-risk Neuroblastoma: A Follow-up of a Case Series in Bratislava." Medicine, vol. 101, no. 4, 2022, p. e28716, https://doi.org/10.1097/MD.0000000000028716.